冠昊生物
(300238)
| 流通市值：31.60亿 | | | 总市值：31.61亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 145,760,495.49 | 144,223,679.34 | 160,604,712.5 | 141,434,634.79 |
| 应收票据及应收账款 | 51,941,139.95 | 61,062,493.63 | 52,452,503.66 | 47,970,229.8 |
| 应收账款 | 51,941,139.95 | 61,062,493.63 | 52,452,503.66 | 47,970,229.8 |
| 预付款项 | 5,114,340.86 | 8,724,153.8 | 5,893,228.22 | 7,589,380.81 |
| 其他应收款合计 | 1,487,564.22 | 1,913,412.1 | 2,962,833.08 | 1,046,683.54 |
| 存货 | 66,182,639.96 | 71,002,809.23 | 77,707,882.85 | 83,499,364.16 |
| 其他流动资产 | 26,828,648.01 | 20,916,018.52 | 25,987,074.68 | 19,192,061.1 |
| 流动资产合计 | 297,314,828.49 | 307,842,566.62 | 325,608,234.99 | 300,732,354.2 |
| 非流动资产: | | | | |
| 长期股权投资 | - | 0 | 191,582.56 | 48,490.18 |
| 其他权益工具投资 | 15,000,000 | 15,000,000 | 15,000,000 | 18,000,000 |
| 投资性房地产 | 7,901,526.01 | 8,012,810.05 | 8,124,094.09 | 8,235,378.13 |
| 固定资产 | 309,237,274.27 | 306,840,740.67 | 309,795,825.82 | 311,609,662.27 |
| 在建工程 | 20,977,219.02 | 21,710,009.96 | 18,025,727.44 | 3,287,470.7 |
| 使用权资产 | 2,489,488.53 | 3,397,121.29 | 4,644,278.86 | 6,640,750.14 |
| 无形资产 | 67,920,533.14 | 70,598,500.14 | 71,813,935.51 | 73,783,553.48 |
| 开发支出 | 33,746,122.31 | 32,411,384.65 | 31,226,678.79 | 29,786,158.81 |
| 长期待摊费用 | 2,360,917.51 | 2,459,334.34 | 2,647,303 | 2,865,049.74 |
| 递延所得税资产 | 19,526,108.69 | 17,676,384.72 | 17,659,283.93 | 18,116,512.48 |
| 其他非流动资产 | 2,911,619.41 | 1,274,119.41 | 1,795,467.2 | 1,401,553.05 |
| 非流动资产合计 | 482,070,808.89 | 479,380,405.23 | 480,924,177.2 | 473,774,578.98 |
| 资产总计 | 779,385,637.38 | 787,222,971.85 | 806,532,412.19 | 774,506,933.18 |
| 流动负债: | | | | |
| 短期借款 | 14,979,387.84 | 14,990,306.43 | 15,000,390.65 | 11,006,535.99 |
| 应付票据及应付账款 | 15,272,252.66 | 13,977,539.25 | 20,129,486.91 | 13,967,590.19 |
| 应付账款 | 15,272,252.66 | 13,977,539.25 | 20,129,486.91 | 13,967,590.19 |
| 预收款项 | 287,583.5 | 171,651.14 | 892,525.22 | 827,670.29 |
| 合同负债 | 24,335,561.56 | 36,568,958.42 | 31,711,176.43 | 29,350,335.12 |
| 应付职工薪酬 | 15,290,440.5 | 12,420,765.91 | 20,301,964.15 | 14,253,921.45 |
| 应交税费 | 7,539,837.07 | 2,011,643.31 | 8,988,598.68 | 8,529,870.43 |
| 其他应付款合计 | 59,417,830.08 | 62,821,457.51 | 63,969,948.68 | 66,977,905.17 |
| 一年内到期的非流动负债 | 5,507,049.84 | 5,733,212.82 | 6,180,557.56 | 5,092,026.42 |
| 其他流动负债 | 1,940,004.29 | 4,904,356.06 | 21,365,900.84 | 2,291,843.69 |
| 流动负债合计 | 144,569,947.34 | 153,599,890.85 | 188,540,549.12 | 152,297,698.75 |
| 非流动负债: | | | | |
| 长期借款 | 114,233,497.57 | 113,243,517.87 | 103,893,230 | 100,950,000 |
| 租赁负债 | 470,468.23 | 1,353,851.64 | 1,852,983.47 | 3,148,612.92 |
| 预计负债 | - | 800,000 | 800,000 | - |
| 递延收益 | 17,602,039.32 | 17,906,516.85 | 18,210,994.38 | 18,515,471.91 |
| 递延所得税负债 | 7,230,797.36 | 5,411,834.38 | 5,417,728.69 | 6,102,261.42 |
| 非流动负债合计 | 139,536,802.48 | 138,715,720.74 | 130,174,936.54 | 128,716,346.25 |
| 负债合计 | 284,106,749.82 | 292,315,611.59 | 318,715,485.66 | 281,014,045 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 265,155,701 | 265,155,701 | 265,155,701 | 265,155,701 |
| 资本公积 | 598,030,498.77 | 598,030,498.77 | 598,030,498.77 | 594,420,828.47 |
| 其他综合收益 | -46,705,871.75 | -46,626,137.73 | -46,514,103.79 | -46,458,339.5 |
| 盈余公积 | 50,974,795.88 | 50,974,795.88 | 50,974,795.88 | 50,643,420.67 |
| 未分配利润 | -284,339,590 | -287,417,099.43 | -297,579,374.88 | -291,640,283.13 |
| 归属于母公司股东权益合计 | 583,115,533.9 | 580,117,758.49 | 570,067,516.98 | 572,121,327.51 |
| 少数股东权益 | -87,836,646.34 | -85,210,398.23 | -82,250,590.45 | -78,628,439.33 |
| 股东权益合计 | 495,278,887.56 | 494,907,360.26 | 487,816,926.53 | 493,492,888.18 |
| 负债和股东权益合计 | 779,385,637.38 | 787,222,971.85 | 806,532,412.19 | 774,506,933.18 |
| 公告日期 | 2026-08-29 | 2026-04-29 | 2026-03-26 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |